Edith B Gralla

Title: The Innovative Contributions of Edith B. Gralla

Introduction

Edith B. Gralla is a notable inventor based in Los Angeles, California. She has made significant contributions to the field of biomedical research, particularly in understanding the mechanisms of familial amyotrophic lateral sclerosis (FALS). Her work has implications for developing treatments for this debilitating condition.

Latest Patents

Edith B. Gralla holds a patent for a method of modulating radical formation by mutant CuZnSOD enzymes. This patent addresses the discovery that FALS-associated mutant CuZnSODs, specifically A4V and G93A, catalyze the generation of hydroxyl radicals from hydrogen peroxide at higher rates than the wild type CuZnSOD. The research indicates that the copper chelator diethyldithiocarbamate (DDC) can inhibit both radical generation and SOD activity of these mutant enzymes at significantly lower concentrations than required for the wild type. In neural cell culture models of FALS, DDC has been shown to reverse the effects of four FALS-associated mutants without affecting the survival of cells expressing only the wild type CuZnSOD. This suggests that radical formation can be modulated, offering potential treatment avenues for patients with mutant CuZnSOD enzymes.

Career Highlights

Throughout her career, Edith has worked with prestigious institutions such as the Burnham Institute and the University of California. Her research has focused on the biochemical pathways involved in neurodegenerative diseases, contributing to a deeper understanding of their underlying mechanisms.

Collaborations

Edith has collaborated with notable colleagues, including Martina Wiedau-Pazos and Dale E. Bredesen. These partnerships have enriched her research and expanded the impact of her findings in the scientific community.

Conclusion

Edith B. Gralla's innovative work in the field of neurobiology and her patent on modulating radical formation highlight her contributions to understanding and potentially treating familial amyotrophic lateral sclerosis. Her research continues to inspire advancements in biomedical science.